Why the study?
Cardiac fibrosis determines prognosis following myocardial infarction, prompting investigation into whether paired-related homeobox 2 regulates Wnt5a gene expression and myocardial fibrosis after infarction.
Does Prrx2 knockdown reduce cardiac fibrosis and improve cardiac function in mice following myocardial infarction?
Does Prrx2 knockdown reduce cardiac fibrosis and improve cardiac function in mice following myocardial infarction?
Answers are grounded in this paper and cite their sources.
Inhibition of Prrx2 alleviates cardiac fibrosis and improves cardiac function post-MI in mice by suppressing Wnt5a signaling, suggesting a potential therapeutic target for ischemic heart disease.
Cardiac fibrosis is a key factor to determine the prognosis in patient with myocardial infarction (MI). The aim of this study is to investigate whether the transcriptional factor paired-related homeobox 2 (Prrx2) regulates Wnt5a gene expression and the role in myocardial fibrosis following MI. The MI surgery was performed by ligation of left anterior descending coronary artery. Cardiac remodelling was assessed by measuring interstitial fibrosis performed with Masson staining. Cell differentiation was examined by analysis the expression of alpha-smooth muscle actin (α-SMA). Both Prrx2 and Wnt5a gene expressions were up-regulated in mice following MI, accompanied with increased mRNA and protein levels of α-SMA, collagen I and collagen III, compared to mice with sham surgery. Adenovirus-mediated gene knock down of Prrx2 increased survival rate, alleviated cardiac fibrosis, decreased infarction sizes and improved cardiac functions in mice with MI. Importantly, inhibition of Prrx2 suppressed ischaemia-induced Wnt5a gene expression and Wnt5a signalling. In cultured cardiac fibroblasts, TGF-β increased gene expressions of Prrx2 and Wnt5a, and induced cell differentiations, which were abolished by gene silence of either Prrx2 or Wnt5a. Further, overexpression of Prrx2 or Wnt5a mirrored the effects of TGF-β on cell differentiations of cardiac fibroblasts. Gene silence of Wnt5a also ablated cell differentiations induced by Prrx2 overexpression in cardiac fibroblasts. Mechanically, Prrx2 was able to bind with Wnt5a gene promoter to up-regulate Wnt5a gene expression. In conclusions, targeting Prrx2-Wnt5a signalling should be considered to improve cardiac remodelling in patients with ischaemic heart diseases.
No takes yet. Share an insight, caveat, or question.
Bai et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: